KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Return on Invested Capital (2016 - 2022)

Arbutus Biopharma (ABUS) has disclosed Return on Invested Capital for 6 consecutive years, with 0.5% as the latest value for Q4 2022.

  • Quarterly Return on Invested Capital changed N/A to 0.5% in Q4 2022 from the year-ago period, while the trailing twelve-month figure was 0.5% through Dec 2022, changed N/A year-over-year, with the annual reading at 0.46% for FY2022, N/A changed from the prior year.
  • Return on Invested Capital hit 0.5% in Q4 2022 for Arbutus Biopharma, down from 0.46% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.23% in Q4 2018 to a low of 1.74% in Q1 2020.
  • Historically, Return on Invested Capital has averaged 0.79% across 4 years, with a median of 0.47% in 2019.
  • Biggest five-year swings in Return on Invested Capital: surged 114bps in 2018 and later plummeted -147bps in 2019.
  • Year by year, Return on Invested Capital stood at 0.23% in 2018, then plummeted by -634bps to 1.7% in 2019, then dropped by -1bps to 1.72% in 2020, then soared by 71bps to 0.5% in 2022.
  • Business Quant data shows Return on Invested Capital for ABUS at 0.5% in Q4 2022, 0.46% in Q3 2022, and 0.43% in Q2 2022.